Orion Pharma Limited (DSE:ORIONPHARM)
Bangladesh · Delayed Price · Currency is BDT 29.10
+2.60 (9.81%)
At close: Oct 15, 2026
Orion Pharma Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 6,809 | 7,090 | 16,169 | 18,626 | 20,592 | 12,613 | |
Market Cap Growth | -11.55% | -56.15% | -13.19% | -9.54% | 63.27% | 28.33% |
Enterprise Value | 35,121 | 32,164 | 39,765 | 42,351 | 40,514 | 28,904 |
Last Close Price | 29.10 | 30.30 | 67.36 | 76.63 | 83.74 | 50.68 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | - | - | 50.83 | 29.06 | 24.34 | 13.43 |
PS Ratio | 2.26 | 1.74 | 1.52 | 1.34 | 2.13 | 1.16 |
PB Ratio | 0.32 | 0.33 | 0.70 | 0.83 | 0.99 | 0.63 |
P/TBV Ratio | 0.34 | 0.35 | 0.75 | 0.89 | 1.07 | 0.68 |
P/FCF Ratio | 16.99 | 21.04 | - | - | - | - |
P/OCF Ratio | 8.29 | 6.42 | 10.19 | 7.47 | 17.73 | 4.87 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 11.66 | 7.88 | 3.74 | 3.04 | 4.19 | 2.67 |
EV/EBITDA Ratio | 80.52 | 47.77 | 26.51 | 26.91 | 35.29 | 11.43 |
EV/EBIT Ratio | - | 575.42 | 42.80 | 42.65 | 60.01 | 18.79 |
EV/FCF Ratio | 87.63 | 95.45 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 1.26 | 1.19 | 1.03 | 0.98 | 0.90 | 0.84 |
Debt / EBITDA Ratio | 63.11 | 37.20 | 15.66 | 13.74 | 15.87 | 6.59 |
Debt / FCF Ratio | 67.46 | 76.20 | - | - | - | - |
Net Debt / Equity Ratio | 1.25 | 1.18 | 1.02 | 0.97 | 0.89 | 0.82 |
Net Debt / EBITDA Ratio | 65.35 | 37.93 | 15.70 | 13.79 | 16.07 | 6.48 |
Net Debt / FCF Ratio | 67.06 | 75.79 | -65.08 | -15.88 | -12.26 | -9.72 |
Asset Turnover | 0.05 | 0.07 | 0.20 | 0.28 | 0.21 | 0.27 |
Inventory Turnover | 1.41 | 1.69 | 5.04 | 7.12 | 5.01 | 6.10 |
Quick Ratio | 1.82 | 1.79 | 1.89 | 1.64 | 1.59 | 2.14 |
Current Ratio | 2.06 | 2.07 | 2.24 | 2.01 | 1.99 | 2.70 |
Return on Equity (ROE) | -2.98% | -2.18% | 1.55% | 3.22% | 4.36% | 5.73% |
Return on Assets (ROA) | -0.15% | 0.06% | 1.08% | 1.23% | 0.93% | 2.43% |
Return on Invested Capital (ROIC) | -0.28% | 0.12% | 1.35% | 1.97% | 1.49% | 4.24% |
Return on Capital Employed (ROCE) | -0.30% | 0.10% | 2.00% | 2.30% | 1.70% | 4.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 14, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | -8.74% | -5.86% | 1.97% | 3.44% | 4.11% | 7.45% |
FCF Yield | 5.89% | 4.75% | -2.24% | -7.33% | -7.31% | -13.36% |
Dividend Yield | - | - | 1.45% | 1.26% | 1.14% | 2.23% |
Payout Ratio | - | - | 84.84% | 23.86% | 38.36% | 36.22% |
Total Shareholder Return | - | - | 1.45% | 1.26% | 1.14% | 2.23% |